Sex-specific declines in cholinergic-targeting tRNA fragments in the nucleus accumbens in Alzheimer’s disease
暂无分享,去创建一个
Y. Loewenstein | E. Mufson | S. Seshadri | H. Soreq | D. Greenberg | David A. Bennett | Nimrod Madrer | I. Paldor | Tamara Zorbaz | Dana Shulman | S. Dubnov | Serafima Dubnov
[1] J. Kipnis,et al. Brain borders at the central stage of neuroimmunology. , 2022, Nature.
[2] M. London,et al. High‐throughput morphometric and transcriptomic profiling uncovers composition of naïve and sensory‐deprived cortical cholinergic VIP/CHAT neurons , 2022, EMBO Journal.
[3] H. Soreq,et al. Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex and Parkinson’s disease-related changes , 2022, bioRxiv.
[4] E. Giacobini,et al. Reimagining cholinergic therapy for Alzheimer's disease. , 2022, Brain : a journal of neurology.
[5] K. Ohi,et al. Differences in subcortical brain volumes among patients with schizophrenia and bipolar disorder and healthy controls , 2022, Journal of psychiatry & neuroscience : JPN.
[6] P. Reddy,et al. Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria , 2021, Ageing Research Reviews.
[7] C. McClung,et al. Sex Differences in Molecular Rhythms in the Human Cortex , 2021, Biological Psychiatry.
[8] V. Menon,et al. Aging disrupts circadian gene regulation and function in macrophages , 2021, Nature Immunology.
[9] V. Swarup,et al. Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies , 2021, Neurobiology of Disease.
[10] H. Soreq,et al. Regulators of cholinergic signaling in disorders of the central nervous system , 2021, Journal of neurochemistry.
[11] A. Schwarz,et al. The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain , 2020, Neuropsychopharmacology.
[12] C. Meisel,et al. Transfer RNA fragments replace microRNA regulators of the cholinergic poststroke immune blockade , 2020, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Fung,et al. Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease , 2020, Aging and disease.
[14] R. Nitsch,et al. Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's disease , 2020, Brain pathology.
[15] P. Quaresma,et al. Cholinergic neurons in the hypothalamus and dorsal motor nucleus of the vagus are directly responsive to growth hormone. , 2020, Life sciences.
[16] A. Hewitt,et al. A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling , 2020, Cells.
[17] Jamie L. Marshall,et al. Disease-associated astrocytes in Alzheimer’s disease and aging , 2020, Nature Neuroscience.
[18] H. Soreq,et al. Cholino‐ncRNAs modulate sex‐specific‐ and age‐related acetylcholine signals , 2020, FEBS letters.
[19] K. Vossel,et al. Neurophysiological signatures in Alzheimer’s disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline , 2020, Science Translational Medicine.
[20] J. Kleinjans,et al. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders , 2019, Progress in Neurobiology.
[21] Joel Nothman,et al. SciPy 1.0-Fundamental Algorithms for Scientific Computing in Python , 2019, ArXiv.
[22] Encyclopedia of Big Data , 2020 .
[23] K. Kosik,et al. Microglial microRNAs mediate sex-specific responses to tau pathology , 2019, Nature Neuroscience.
[24] H. Soreq,et al. Integrative Transcriptomics Reveals Sexually Dimorphic Control of the Cholinergic/Neurokine Interface in Schizophrenia and Bipolar Disorder , 2019, Cell reports.
[25] C. A. Toro,et al. Sex differences in Alzheimer’s disease: Understanding the molecular impact , 2019, Brain Research.
[26] L. Rodella,et al. Sex differences of brain and their implications for personalized therapy. , 2019, Pharmacological research.
[27] H. Fillit,et al. Translating the biology of aging into novel therapeutics for Alzheimer disease , 2018, Neurology.
[28] C. Thorn,et al. Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline. , 2018, ACS chemical neuroscience.
[29] D. Grozeva,et al. Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer’s disease , 2019, PloS one.
[30] for the Alzheimer’s Disease Neuroimaging Initiative,et al. Sex differences in Alzheimer disease — the gateway to precision medicine , 2018, Nature Reviews Neurology.
[31] B. Winblad,et al. Targeting Alzheimer's disease with gene and cell therapies , 2018, Journal of internal medicine.
[32] David A Bennett,et al. Religious Orders Study and Rush Memory and Aging Project. , 2018, Journal of Alzheimer's disease : JAD.
[33] Kristel Sleegers,et al. Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics. , 2018, Trends in genetics : TIG.
[34] M. Mesulam,et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. , 2018, Brain : a journal of neurology.
[35] Z. Werb,et al. Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity , 2018, Nature Communications.
[36] Marcus K. Dymond,et al. PCYT1A Regulates Phosphatidylcholine Homeostasis from the Inner Nuclear Membrane in Response to Membrane Stored Curvature Elastic Stress , 2018, Developmental cell.
[37] D. Bartel. Metazoan MicroRNAs , 2018, Cell.
[38] E. Mufson,et al. Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease , 2018, Journal of neuropathology and experimental neurology.
[39] G. Fink,et al. Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer’s disease , 2018, Brain : a journal of neurology.
[40] S. Mocellin,et al. Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies , 2018, BMC Medicine.
[41] Fabian J Theis,et al. SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.
[42] S. Dudoit,et al. A general and flexible method for signal extraction from single-cell RNA-seq data , 2018, Nature Communications.
[43] Miles R. Fontenot,et al. Novel transcriptional networks regulated by CLOCK in human neurons , 2017, Genes & development.
[44] C. Masters,et al. A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain , 2017, Nature Reviews Neurology.
[45] Zhaoyang Feng,et al. A conserved KLF-autophagy pathway modulates nematode lifespan and mammalian age-associated vascular dysfunction , 2017, Nature Communications.
[46] M. Giovannini,et al. The fate of the brain cholinergic neurons in neurodegenerative diseases , 2017, Brain Research.
[47] M. Häusser,et al. NKX2-1 Is Required in the Embryonic Septum for Cholinergic System Development, Learning, and Memory , 2017, Cell reports.
[48] Manuel A. S. Santos,et al. Discovery and function of transfer RNA‐derived fragments and their role in disease , 2017, Wiley interdisciplinary reviews. RNA.
[49] R. Fields,et al. Cholinergic signaling in myelination , 2017, Glia.
[50] Y. Jo,et al. Cholinergic neurons in the dorsomedial hypothalamus regulate food intake , 2017, Molecular metabolism.
[51] Michael Becker,et al. FDR-controlled metabolite annotation for high-resolution imaging mass spectrometry , 2016, Nature Methods.
[52] Valentine Svensson,et al. Power Analysis of Single Cell RNA-Sequencing Experiments , 2016, Nature Methods.
[53] Sterling C. Johnson,et al. Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology , 2016, Nature Communications.
[54] A. Grimm,et al. Alzheimer, mitochondria and gender , 2016, Neuroscience & Biobehavioral Reviews.
[55] Canan Kuscu,et al. Biogenesis and Function of Transfer RNA-Related Fragments (tRFs). , 2016, Trends in biochemical sciences.
[56] Konstantina S. Nikita,et al. Bioinformatics methods in drug repurposing for Alzheimer's disease , 2016, Briefings Bioinform..
[57] Aleksandra A. Kolodziejczyk,et al. Classification of low quality cells from single-cell RNA-seq data , 2016, Genome Biology.
[58] A. Sharp,et al. Genome-wide12 DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer’s disease , 2016, Genome Medicine.
[59] Matthew L Senjem,et al. Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span. , 2015, JAMA neurology.
[60] Frederik Barkhof,et al. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[61] Aristeidis G Telonis,et al. Mitochondrial tRNA-lookalikes in nuclear chromosomes: Could they be functional? , 2015, RNA biology.
[62] G. Acquaah-Mensah,et al. A regulatory role for the insulin- and BDNF-linked RORA in the hippocampus: implications for Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.
[63] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[64] B. Williams,et al. From single-cell to cell-pool transcriptomes: Stochasticity in gene expression and RNA splicing , 2014, Genome research.
[65] Alexander J. Westermann,et al. Single-cell RNA-seq: advances and future challenges , 2014, Nucleic acids research.
[66] Aikaterini S. Papadopoulou,et al. Alteration of the microRNA network during the progression of Alzheimer's disease , 2013, EMBO molecular medicine.
[67] Mohammad Wahid Ansari,et al. The legal status of in vitro embryos , 2014 .
[68] Martin Reczko,et al. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows , 2013, Nucleic Acids Res..
[69] Haitao Luo,et al. Inhibition of cholinergic signaling causes apoptosis in human bronchioalveolar carcinoma , 2013, Cancer research.
[70] Vladislav A Petyuk,et al. Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains. , 2012, Journal of proteome research.
[71] Ivo Grosse,et al. Functional microRNA targets in protein coding sequences , 2012, Bioinform..
[72] H. Hirase,et al. Astrocyte Calcium Signaling Transforms Cholinergic Modulation to Cortical Plasticity In Vivo , 2011, The Journal of Neuroscience.
[73] E. Nestler,et al. Transcriptional and epigenetic mechanisms of addiction , 2011, Nature Reviews Neuroscience.
[74] Nick C Fox,et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[75] P. Blain,et al. Mitochondrial Dysfunction in Parkinson's Disease , 2011, Parkinson's disease.
[76] V. Yang,et al. Mammalian Krüppel-like factors in health and diseases. , 2010, Physiological reviews.
[77] George T. Grossberg,et al. Circadian Rhythm Disturbances in Patients with Alzheimer's Disease: A Review , 2010, International journal of Alzheimer's disease.
[78] K. Tracey,et al. Cholinergic control of inflammation , 2009, Journal of internal medicine.
[79] L. Pessoa. How do emotion and motivation direct executive control? , 2009, Trends in Cognitive Sciences.
[80] R. McGlinchey,et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. , 2008, Archives of internal medicine.
[81] M. Beal,et al. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. , 2008, Trends in molecular medicine.
[82] David A. Bennett,et al. Decision Rules Guiding the Clinical Diagnosis of Alzheimer’s Disease in Two Community-Based Cohort Studies Compared to Standard Practice in a Clinic-Based Cohort Study , 2006, Neuroepidemiology.
[83] J. Schneider,et al. Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.
[84] J. Blusztajn,et al. Expression of high affinity choline transporter during mouse development in vivo and its upregulation by NGF and BMP-4 in vitro. , 2005, Brain research. Developmental brain research.
[85] A. Sekine,et al. Single nucleotide polymorphisms in the gene encoding Krüppel-like factor 7 are associated with type 2 diabetes , 2005, Diabetologia.
[86] M. Follettie,et al. Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[87] J. Schneider,et al. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions , 2005, Neurology.
[88] L. Miraglia,et al. A Functional Genomics Strategy Reveals Rora as a Component of the Mammalian Circadian Clock , 2004, Neuron.
[89] Roland Baron,et al. BMP‐2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine Loop , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[90] J. Buccafusco,et al. The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development , 2003, Journal of Pharmacology and Experimental Therapeutics.
[91] Charles J. Wilson,et al. Cholinergic interneuron characteristics and nicotinic properties in the striatum. , 2002, Journal of neurobiology.
[92] D. A. Bennett,et al. Natural history of mild cognitive impairment in older persons , 2002, Neurology.
[93] J. Barrett,et al. Bone morphogenetic proteins (BMP6 and BMP7) enhance the protective effect of neurotrophins on cultured septal cholinergic neurons during hypoglycemia , 2001, Journal of neurochemistry.
[94] J. Lindsay,et al. Physical activity and risk of cognitive impairment and dementia in elderly persons. , 2001, Archives of neurology.
[95] David J. Anderson,et al. Neural Crest Stem Cells Undergo Cell-Intrinsic Developmental Changes in Sensitivity to Instructive Differentiation Signals , 2001, Neuron.
[96] J. Martinou,et al. Cholinergic differentiation factor (CDF/LIF) promotes survival of isolated rat embryonic motoneurons in vitro , 1992, Neuron.
[97] H. Hatanaka,et al. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures , 1991, Neuroscience.
[98] J. McManaman,et al. Skeletal Muscle Proteins Stimulate Cholinergic Differentiation of Human Neuroblastoma Cells , 1991, Journal of neurochemistry.
[99] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[100] Yves-Alain Barde,et al. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture , 1990, Neuron.
[101] H. Groenewegen,et al. The distribution and compartmental organization of the cholinergic neurons in nucleus accumbens of the rat , 1989, Neuroscience.
[102] H. Fibiger,et al. The organization and some projections of cholinergic neurons of the mammalian forebrain , 1982, Brain Research Reviews.
[103] R. Bartus,et al. The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.
[104] H. Fibiger,et al. Acetylcholinesterase and the cholinergic neuron. , 1979, Life sciences.
[105] John C. Parker,et al. “This culture” , 1940, Electrical Engineering.